These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9086131)

  • 1. The interleukin-2 fusion protein, DAB389IL-2, inhibits the development of infectious virus in human immunodeficiency virus type 1-infected human peripheral blood mononuclear cells.
    Zhang LJ; Waters CA; Poisson LR; Estis LF; Crumpacker CS
    J Infect Dis; 1997 Apr; 175(4):790-4. PubMed ID: 9086131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HIV-1 RNA production by the diphtheria toxin-related IL-2 fusion proteins DAB486IL-2 and DAB389IL-2.
    Zhang L; Waters C; Nichols J; Crumpacker C
    J Acquir Immune Defic Syndr (1988); 1992 Dec; 5(12):1181-7. PubMed ID: 1453329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An IL-2-toxin, DAB389IL-2, inhibits delayed-type hypersensitivity but enhances IgE antibody production.
    Pullerits T; Lundin S; Dahlgren U; Telemo E; Hanson LA; Lötvall J
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):843-9. PubMed ID: 10329818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DAB
    Bhopale MK; Hilliard B; Constantinescu CS; Phillips SM; Rostami A
    Immunopharmacol Immunotoxicol; 2017 Dec; 39(6):318-329. PubMed ID: 28929835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 fusion protein (DAB389IL-2) selectively targets activated human peripheral blood and lamina propria lymphocytes.
    Bousvaros A; Stevens AC; Strom TB; Murphy J; Lamont JT
    Dig Dis Sci; 1997 Jul; 42(7):1542-8. PubMed ID: 9246061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of immunopathology in schistosomiasis by interleukin-2-targeted fusion toxin, DAB389IL-2. I. Studies of in vitro and in vivo efficacy.
    Ramadan MA; Gabr NS; Bacha P; Günzler V; Phillips SM
    Cell Immunol; 1995 Dec; 166(2):217-26. PubMed ID: 7497523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells.
    Choi HJ; Dinarello CA; Shapiro L
    J Infect Dis; 2001 Sep; 184(5):560-8. PubMed ID: 11494162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 alpha increases the preferential cytotoxicity of an interleukin-2-diphtheria toxin fusion protein against neoplastic lymphocytes from patients with the Sezary syndrome compared to normal lymphocytes.
    Salard D; Kuzel TM; Samuelson E; Rosen S; Bakouche O
    J Clin Immunol; 1998 May; 18(3):223-34. PubMed ID: 9624582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 receptor expression by human B cells: functional analysis with a human interleukin-4 toxin, DAB389IL-4.
    Jabara HH; Vercelli D; Schneider LC; Williams DP; Genbauffe FS; Poisson LR; Waters CA; Geha RS
    J Allergy Clin Immunol; 1995 Apr; 95(4):893-900. PubMed ID: 7722171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro selective elimination of HIV-infected cells from peripheral blood in AIDS patients by the immunotoxin DAB389CD4.
    Martín-Serrano J; Folgueira L; Laín de Lera T; Pedraza MA; Lemichez E; Sánchez-Palomino S; Noriega AR; Boquet P; Alcamí J
    AIDS; 1998 May; 12(8):859-63. PubMed ID: 9631138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 fusion protein: an investigational therapy for interleukin-2 receptor expressing malignancies.
    Nichols J; Foss F; Kuzel TM; LeMaistre CF; Platanias L; Ratain MJ; Rook A; Saleh M; Schwartz G
    Eur J Cancer; 1997 Jan; 33 Suppl 1():S34-6. PubMed ID: 9166099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-2-oxothiazolidine-4-carboxylic acid (procysteine) inhibits expression of the human immunodeficiency virus and expression of the interleukin-2 receptor alpha chain.
    Lederman MM; Georges D; Dando S; Schmelzer R; Averill L; Goldberg D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):107-15. PubMed ID: 7834394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of interleukin-12, interleukin-15, and interleukin-2 on human immunodeficiency virus type 1 replication in vitro.
    Bayard-McNeeley M; Doo H; He S; Hafner A; Johnson WD; Ho JL
    Clin Diagn Lab Immunol; 1996 Sep; 3(5):547-53. PubMed ID: 8877133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective elimination of HIV-1-infected cells with an interleukin-2 receptor-specific cytotoxin.
    Finberg RW; Wahl SM; Allen JB; Soman G; Strom TB; Murphy JR; Nichols JC
    Science; 1991 Jun; 252(5013):1703-5. PubMed ID: 1904628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis.
    Ho JL; He S; Hu A; Geng J; Basile FG; Almeida MG; Saito AY; Laurence J; Johnson WD
    J Exp Med; 1995 Apr; 181(4):1493-505. PubMed ID: 7699332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2.
    LeMaistre CF; Saleh MN; Kuzel TM; Foss F; Platanias LC; Schwartz G; Ratain M; Rook A; Freytes CO; Craig F; Reuben J; Nichols JC
    Blood; 1998 Jan; 91(2):399-405. PubMed ID: 9427692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of interleukin 12 on in vitro HIV type 1 replication depends on clinical stage.
    Perales MA; Skolnik PR; Lieberman J
    AIDS Res Hum Retroviruses; 1996 May; 12(8):659-68. PubMed ID: 8744576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 2 (IL-2) receptor expression and sensitivity to diphteria fusion toxin DAB389IL-2 in cultured hematopoietic cells.
    Re GG; Waters C; Poisson L; Willingham MC; Sugamura K; Frankel AE
    Cancer Res; 1996 Jun; 56(11):2590-5. PubMed ID: 8653702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells.
    Mascola JR; Louder MK; Winter C; Prabhakara R; De Rosa SC; Douek DC; Hill BJ; Gabuzda D; Roederer M
    J Virol; 2002 May; 76(10):4810-21. PubMed ID: 11967298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.